Search for: "Janssen Research "
Results 41 - 60
of 200
Sort by Relevance
|
Sort by Date
29 Mar 2018, 11:39 am
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
29 Mar 2018, 11:39 am
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
5 Mar 2018, 4:25 pm
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
5 Mar 2018, 4:25 pm
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
5 Jan 2018, 12:00 pm
Categories: SGLT-2 Inhibitors Diabetes Drugs Hepatitis C Treatment Drugs Anticoagulants / Bloodthinners Breast Implants Osteoporosis Treatment Drugs Erectile Dysfunction (ED) Drugs Heartburn / Acid Reflux Drugs Multiple Sclerosis (MS) Treatment Drugs DPP-4 Inhibitors Diabetes Drugs Miscellaneous SGLT-2 Inhibitors Diabetes Drugs: Jardiance - Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of... post hoc analyses" (11/28/17) Medical… [read post]
18 Dec 2017, 12:11 pm
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
18 Dec 2017, 12:11 pm
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
2 Nov 2017, 9:00 pm
Several top experts are attending the workshop, with funding from the Janssen Vaccines and the College of Agricultural Sciences’ Office for Research and Graduate Education. [read post]
2 Nov 2017, 9:23 am
Do your research on the attorney and take your time with this important decision. [read post]
24 Oct 2017, 12:30 pm
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) During this year we have written several times about the still developing drug safety issue of lower limb amputations linked to Invokana use: A "Dear Doctor" Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada Analysis Of FDA Adverse Event… [read post]
24 Sep 2017, 2:22 pm
McIntosh, DVM, Veterinary Medical Officer, USDA, APHIS Animal Reproducibility & Relatability of Animal Research to Human Research Panelists: Damir Hamamdzic, DVM, PhD, Research and Regulatory Affairs, Post-Approval Monitoring Compliance Administrator, Rutgers University Sarah E. [read post]
10 Aug 2017, 2:35 pm
This New Medical Research Was Published Just Before "Black-Box Warning" About Lower Limb Amputations Added To Drug Labels (Posted by Tom Lamb at DrugInjuryWatch.com) In the final week of July 2017, the FDA issued a notification that it had approved a revised drug label for Invokana and Invokamet, as well as a revised Medication Guide for these two diabetes drugs from Janssen Pharmaceuticals. [read post]
11 Jul 2017, 2:30 am
According to research of IP Kat, and ‘if there are no further delays or unexpected hurdles, (…) it may be that the UK may have ratified the UPC by end of November/early December 2017’. [read post]
11 Jul 2017, 2:30 am
According to research of IP Kat, and ‘if there are no further delays or unexpected hurdles, (…) it may be that the UK may have ratified the UPC by end of November/early December 2017’. [read post]
30 May 2017, 5:17 am
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
30 May 2017, 5:17 am
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
4 May 2017, 1:00 am
The clinical research of pharmaceutical polymorphs commenced in 1950s internationally though, it was until in mid-1990s did Chinese research institutions and pharmaceutical enterprises recognize the importance of pharmaceutical polymorphs after the first awareness of the significant efficacy difference between imported nimodipine and the homemade one. [read post]
1 May 2017, 8:00 am
This drug was researched, developed, manufactured and marketed by GSK. [read post]
